Section 10 PE Tables – Results from the 2021 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

220708

Table 10.1A – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 18 or Older with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	AMONG ADULTS WHO HAD SERIOUS THOUGHTS OF SUICIDE	AMONG ADULTS WHO MADE ANY SUICIDE PLANS	AMONG ADULTS WHO ATTEMPTED SUICIDE
Demographic Characteristic	Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic (2021)	Made Any Suicide Plans Because of the COVID-19 Pandemic (2021)	Attempted Suicide Because of the COVID-19 Pandemic (2021)
TOTAL	1,941	483	279
AGE GROUP
18-25	667	209	87
26 or Older	1,274	274	*
26-49	1,030	245	*
50 or Older	243	*	*
GENDER
Male	896	296	*
Female	1,045	188	89
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,570	330	152
White	1,070	227	72
Black or African American	313	*	*
AIAN	*	*	*
NHOPI	*	*	*
Asian	52	*	*
Two or More Races	*	*	*
Hispanic or Latino	371	*	*
EMPLOYMENT STATUS
Full-Time	771	193	*
Part-Time	287	89	*
Unemployed	305	*	*
Other¹	579	117	75
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.1B – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 18 or Older with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Percentages, 2021
Demographic Characteristic	AMONG ADULTS WHO HAD SERIOUS THOUGHTS OF SUICIDE	AMONG ADULTS WHO MADE ANY SUICIDE PLANS	AMONG ADULTS WHO ATTEMPTED SUICIDE
Demographic Characteristic	Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic (2021)	Made Any Suicide Plans Because of the COVID-19 Pandemic (2021)	Attempted Suicide Because of the COVID-19 Pandemic (2021)
TOTAL	15.8	13.7	16.0
AGE GROUP
18-25	15.3	12.7	9.6
26 or Older	16.0	14.6	*
26-49	18.6	16.5	*
50 or Older	10.1	*	*
GENDER
Male	16.3	18.7	*
Female	15.4	9.6	8.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.4	11.9	12.2
White	13.7	10.6	8.5
Black or African American	22.1	*	*
AIAN	*	*	*
NHOPI	*	*	*
Asian	13.3	*	*
Two or More Races	*	*	*
Hispanic or Latino	17.5	*	*
EMPLOYMENT STATUS
Full-Time	15.5	16.1	*
Part-Time	13.3	13.6	*
Unemployed	22.2	*	*
Other¹	15.3	10.0	12.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.2A – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 12 to 17 with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	AMONG YOUTHS WHO HAD SERIOUS THOUGHTS OF SUICIDE	AMONG YOUTHS WHO MADE ANY SUICIDE PLANS	AMONG YOUTHS WHO ATTEMPTED SUICIDE
Demographic Characteristic	Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic (2021)	Made Any Suicide Plans Because of the COVID-19 Pandemic (2021)	Attempted Suicide Because of the COVID-19 Pandemic (2021)
TOTAL	484	178	73
12-13	112	46	26
14-15	197	86	19
16-17	174	47	*
GENDER
Male	160	41	*
Female	324	137	38
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	396	147	58
White	264	85	35
Black or African American	65	*	*
AIAN	*	*	*
NHOPI	*	*	*
Asian	*	*	*
Two or More Races	*	*	*
Hispanic or Latino	88	32	16
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their suicidal thoughts or behaviors because of the COVID-19 pandemic were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.2B – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 12 to 17 with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Percentages, 2021
Demographic Characteristic	AMONG YOUTHS WHO HAD SERIOUS THOUGHTS OF SUICIDE	AMONG YOUTHS WHO MADE ANY SUICIDE PLANS	AMONG YOUTHS WHO ATTEMPTED SUICIDE
Demographic Characteristic	Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic (2021)	Made Any Suicide Plans Because of the COVID-19 Pandemic (2021)	Attempted Suicide Because of the COVID-19 Pandemic (2021)
TOTAL	15.1	12.0	8.4
12-13	13.2	10.1	9.1
14-15	18.2	17.2	6.3
16-17	13.7	8.7	*
GENDER
Male	15.6	9.9	*
Female	14.8	12.7	6.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	16.4	14.2	9.5
White	16.3	12.2	9.3
Black or African American	15.7	*	*
AIAN	*	*	*
NHOPI	*	*	*
Asian	*	*	*
Two or More Races	*	*	*
Hispanic or Latino	11.1	7.0	5.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their suicidal thoughts or behaviors because of the COVID-19 pandemic were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.3A – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Used Drugs a Little Less or Much Less than before the Pandemic (2021)	Used Drugs about the Same as before the Pandemic (2021)	Used Drugs a Little More or Much More than before the Pandemic (2021)
TOTAL	39,673	56,968	10,236
AGE GROUP
12-17	2,665	1,801	654
18 or Older	37,009	55,166	9,582
18-25	5,455	7,002	2,543
26 or Older	31,554	48,164	7,039
GENDER
Male	19,291	27,362	4,738
Female	20,382	29,605	5,498
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	32,717	51,023	8,729
White	22,968	42,570	6,546
Black or African American	6,483	5,287	1,512
AIAN	428	390	98
NHOPI	*	*	*
Asian	1,439	1,437	271
Two or More Races	1,103	1,229	276
Hispanic or Latino	6,956	5,945	1,507
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded. NOTE: Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.3B – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Used Drugs a Little Less or Much Less than before the Pandemic (2021)	Used Drugs about the Same as before the Pandemic (2021)	Used Drugs a Little More or Much More than before the Pandemic (2021)
TOTAL	37.1	53.3	9.6
AGE GROUP
12-17	52.0	35.2	12.8
18 or Older	36.4	54.2	9.4
18-25	36.4	46.7	17.0
26 or Older	36.4	55.5	8.1
GENDER
Male	37.5	53.2	9.2
Female	36.7	53.4	9.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	35.4	55.2	9.4
White	31.9	59.1	9.1
Black or African American	48.8	39.8	11.4
AIAN	46.7	42.6	10.7
NHOPI	*	*	*
Asian	45.7	45.7	8.6
Two or More Races	42.3	47.1	10.6
Hispanic or Latino	48.3	41.3	10.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded. NOTE: Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.4A – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Used Drugs a Little Less or Much Less than before the Pandemic (2021)	Used Drugs about the Same as before the Pandemic (2021)	Used Drugs a Little More or Much More than before the Pandemic (2021)
TOTAL	39,673	56,968	10,236
GEOGRAPHIC REGION
Northeast	5,820	9,725	2,131
Midwest	8,211	12,946	2,074
South	16,234	20,240	3,076
West	9,408	14,056	2,955
COUNTY TYPE
Large Metro	20,317	30,147	6,190
Small Metro	12,529	18,687	3,115
Nonmetro	6,827	8,133	931
Urbanized	2,592	3,314	422
Less Urbanized	3,515	4,042	439
Completely Rural	720	776	70
POVERTY LEVEL¹
Less Than 100%	8,496	6,738	1,981
100-199%	9,253	10,279	2,102
200% or More	21,923	39,939	6,148
HEALTH INSURANCE²
Private	19,834	36,756	5,868
Medicaid/CHIP	11,669	9,767	2,880
Other³	12,557	15,230	1,708
No Coverage	4,205	4,654	927
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded. NOTE: Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.4B – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Used Drugs a Little Less or Much Less than before the Pandemic (2021)	Used Drugs about the Same as before the Pandemic (2021)	Used Drugs a Little More or Much More than before the Pandemic (2021)
TOTAL	37.1	53.3	9.6
GEOGRAPHIC REGION
Northeast	32.9	55.0	12.1
Midwest	35.3	55.7	8.9
South	41.0	51.2	7.8
West	35.6	53.2	11.2
COUNTY TYPE
Large Metro	35.9	53.2	10.9
Small Metro	36.5	54.4	9.1
Nonmetro	43.0	51.2	5.9
Urbanized	41.0	52.4	6.7
Less Urbanized	44.0	50.6	5.5
Completely Rural	46.0	49.6	4.5
POVERTY LEVEL¹
Less Than 100%	49.3	39.1	11.5
100-199%	42.8	47.5	9.7
200% or More	32.2	58.7	9.0
HEALTH INSURANCE²
Private	31.8	58.8	9.4
Medicaid/CHIP	48.0	40.2	11.8
Other³	42.6	51.6	5.8
No Coverage	43.0	47.6	9.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded. NOTE: Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.5A – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Used Alcohol a Little Less or Much Less than before the Pandemic (2021)	Used Alcohol about the Same as before the Pandemic (2021)	Used Alcohol a Little More or Much More than before the Pandemic (2021)
TOTAL	49,795	95,591	22,661
AGE GROUP
12-20¹	3,734	4,617	1,509
21 or Older¹	46,060	90,974	21,152
12-17	1,571	1,634	638
18 or Older	48,223	93,957	22,023
18-25	7,089	11,129	3,115
26 or Older	41,134	82,828	18,908
GENDER
Male	25,184	48,294	10,828
Female	24,610	47,297	11,833
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	38,305	83,644	19,624
White	27,076	68,559	15,995
Black or African American	7,165	8,801	2,188
AIAN	365	*	94
NHOPI	*	*	*
Asian	2,431	3,920	807
Two or More Races	964	1,707	515
Hispanic or Latino	11,489	11,948	3,037
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded. ¹ The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.5B – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Used Alcohol a Little Less or Much Less than before the Pandemic (2021)	Used Alcohol about the Same as before the Pandemic (2021)	Used Alcohol a Little More or Much More than before the Pandemic (2021)
TOTAL	29.6	56.9	13.5
AGE GROUP
12-20¹	37.9	46.8	15.3
21 or Older¹	29.1	57.5	13.4
12-17	40.9	42.5	16.6
18 or Older	29.4	57.2	13.4
18-25	33.2	52.2	14.6
26 or Older	28.8	58.0	13.2
GENDER
Male	29.9	57.3	12.8
Female	29.4	56.5	14.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	27.1	59.1	13.9
White	24.3	61.4	14.3
Black or African American	39.5	48.5	12.1
AIAN	37.0	*	9.5
NHOPI	*	*	*
Asian	34.0	54.8	11.3
Two or More Races	30.3	53.6	16.2
Hispanic or Latino	43.4	45.1	11.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded. ¹ The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.6A – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Used Alcohol a Little Less or Much Less than before the Pandemic (2021)	Used Alcohol about the Same as before the Pandemic (2021)	Used Alcohol a Little More or Much More than before the Pandemic (2021)
TOTAL	49,795	95,591	22,661
GEOGRAPHIC REGION
Northeast	8,402	17,806	4,243
Midwest	10,472	22,206	4,806
South	18,658	35,581	7,293
West	12,263	19,999	6,319
COUNTY TYPE
Large Metro	27,925	51,015	14,175
Small Metro	14,977	30,482	6,370
Nonmetro	6,892	14,094	2,116
Urbanized	2,538	5,658	932
Less Urbanized	3,554	7,235	1,028
Completely Rural	800	1,202	155
POVERTY LEVEL¹
Less Than 100%	8,394	8,292	2,203
100-199%	10,133	14,645	2,845
200% or More	31,266	72,629	17,610
HEALTH INSURANCE²
Private	29,192	66,856	16,228
Medicaid/CHIP	10,737	11,099	2,925
Other³	12,529	25,868	3,312
No Coverage	5,563	7,602	2,080
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.6B – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Used Alcohol a Little Less or Much Less than before the Pandemic (2021)	Used Alcohol about the Same as before the Pandemic (2021)	Used Alcohol a Little More or Much More than before the Pandemic (2021)
TOTAL	29.6	56.9	13.5
GEOGRAPHIC REGION
Northeast	27.6	58.5	13.9
Midwest	27.9	59.2	12.8
South	30.3	57.8	11.9
West	31.8	51.8	16.4
COUNTY TYPE
Large Metro	30.0	54.8	15.2
Small Metro	28.9	58.8	12.3
Nonmetro	29.8	61.0	9.2
Urbanized	27.8	62.0	10.2
Less Urbanized	30.1	61.2	8.7
Completely Rural	37.1	55.7	7.2
POVERTY LEVEL¹
Less Than 100%	44.4	43.9	11.7
100-199%	36.7	53.0	10.3
200% or More	25.7	59.8	14.5
HEALTH INSURANCE²
Private	26.0	59.5	14.5
Medicaid/CHIP	43.4	44.8	11.8
Other³	30.0	62.0	7.9
No Coverage	36.5	49.9	13.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.7A – Perceived COVID-19 Pandemic Effect on Access to Substance Use Treatment: Among People Aged 12 or Older, among People Aged 12 or Older with Illicit Drug or Alcohol Use in Past Year, and among People Aged 12 or Older with Illicit Drug or Alcohol Use Disorder in Past Year; by Age Group, Numbers in Thousands, 2021
Perceived Effect on Access to Substance Use Treatment	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	23,307	1,521	21,785	2,015	19,770
Delays or cancellations in appointments	21,298	2,161	19,137	1,905	17,232
Delays in getting prescriptions	10,125	817	9,308	935	8,373
Unable to access needed care resulting in moderate or severe impact on health	7,194	503	6,691	729	5,963
PERCEIVED EFFECT AMONG PAST YEAR ILLICIT DRUG OR ALCOHOL USERS
Appointments moved from in-person to telehealth	14,827	462	14,366	1,442	12,923
Delays or cancellations in appointments	12,880	577	12,302	1,332	10,970
Delays in getting prescriptions	6,010	285	5,726	659	5,067
Unable to access needed care resulting in moderate or severe impact on health	4,321	207	4,114	535	3,578
PERCEIVED EFFECT AMONG PEOPLE WITH PAST YEAR ILLICIT DRUG OR ALCOHOL USE DISORDER¹
Appointments moved from in-person to telehealth	4,982	226	4,756	682	4,074
Delays or cancellations in appointments	4,382	236	4,146	580	3,566
Delays in getting prescriptions	2,536	178	2,358	331	2,027
Unable to access needed care resulting in moderate or severe impact on health	2,161	126	2,035	278	1,757
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to substance use treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their access to substance use treatment were excluded. ¹ Illicit drug or alcohol use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.7B – Perceived COVID-19 Pandemic Effect on Access to Substance Use Treatment: Among People Aged 12 or Older, among People Aged 12 or Older with Illicit Drug or Alcohol Use in Past Year, and among People Aged 12 or Older with Illicit Drug or Alcohol Use Disorder in Past Year; by Age Group, Percentages, 2021
Perceived Effect on Access to Substance Use Treatment	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	8.5	6.1	8.7	6.1	9.1
Delays or cancellations in appointments	7.8	8.7	7.7	5.8	7.9
Delays in getting prescriptions	3.7	3.3	3.7	2.9	3.9
Unable to access needed care resulting in moderate or severe impact on health	2.6	2.0	2.7	2.2	2.8
PERCEIVED EFFECT AMONG PAST YEAR ILLICIT DRUG OR ALCOHOL USERS
Appointments moved from in-person to telehealth	8.2	7.9	8.2	6.2	8.5
Delays or cancellations in appointments	7.1	9.9	7.0	5.7	7.2
Delays in getting prescriptions	3.3	4.9	3.3	2.8	3.3
Unable to access needed care resulting in moderate or severe impact on health	2.4	3.6	2.3	2.3	2.3
PERCEIVED EFFECT AMONG PEOPLE WITH PAST YEAR ILLICIT DRUG OR ALCOHOL USE DISORDER¹
Appointments moved from in-person to telehealth	11.9	12.0	11.9	8.4	12.8
Delays or cancellations in appointments	10.5	12.6	10.4	7.1	11.2
Delays in getting prescriptions	6.1	9.5	5.9	4.1	6.4
Unable to access needed care resulting in moderate or severe impact on health	5.2	6.7	5.1	3.4	5.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to substance use treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their access to substance use treatment were excluded. ¹ Illicit drug or alcohol use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.8A – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021
Perceived Negative Effect on Emotional or Mental Health	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG TOTAL POPULATION
Not at all	89,660	10,632	79,028	35,089	43,939
A little or some	124,370	15,226	109,145	48,296	60,849
Quite a bit or a lot	36,125	7,078	29,047	17,450	11,597
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE
Not at all	2,534	636	1,897	1,170	727
A little or some	8,672	2,385	6,287	3,823	2,465
Quite a bit or a lot	9,440	3,096	6,345	4,391	1,953
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE WITH SEVERE IMPAIRMENT
Not at all	1,653	406	1,247	742	504
A little or some	5,515	1,549	3,966	2,399	1,567
Quite a bit or a lot	6,998	2,388	4,610	3,370	1,241
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH NO PAST YEAR MDE
Not at all	87,127	9,996	77,131	33,919	43,212
A little or some	115,698	12,841	102,857	44,473	58,384
Quite a bit or a lot	26,685	3,982	22,703	13,059	9,644
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.8B – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021
Perceived Negative Effect on Emotional or Mental Health	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG TOTAL POPULATION
Not at all	35.8	32.3	36.4	34.8	37.8
A little or some	49.7	46.2	50.2	47.9	52.3
Quite a bit or a lot	14.4	21.5	13.4	17.3	10.0
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE
Not at all	12.3	10.4	13.1	12.5	14.1
A little or some	42.0	39.0	43.3	40.7	47.9
Quite a bit or a lot	45.7	50.6	43.7	46.8	38.0
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE WITH SEVERE IMPAIRMENT
Not at all	11.7	9.3	12.7	11.4	15.2
A little or some	38.9	35.7	40.4	36.8	47.3
Quite a bit or a lot	49.4	55.0	46.9	51.8	37.5
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH NO PAST YEAR MDE
Not at all	38.0	37.3	38.1	37.1	38.8
A little or some	50.4	47.9	50.7	48.6	52.5
Quite a bit or a lot	11.6	14.8	11.2	14.3	8.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.9A – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Numbers in Thousands, 2021
Perceived Negative Effect on Emotional or Mental Health	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG TOTAL POPULATION
Not at all	89,660	10,632	79,028	35,089	43,939
A little or some	124,370	15,226	109,145	48,296	60,849
Quite a bit or a lot	36,125	7,078	29,047	17,450	11,597
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR ANY MENTAL ILLNESS
Not at all	9,190	1,528	7,662	4,376	3,286
A little or some	26,824	4,880	21,945	12,930	9,015
Quite a bit or a lot	20,449	4,613	15,836	10,836	5,000
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR SERIOUS MENTAL ILLNESS
Not at all	1,592	374	1,218	864	354
A little or some	5,519	1,409	4,110	2,702	1,408
Quite a bit or a lot	6,815	1,990	4,825	3,632	1,194
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH NO PAST YEAR MENTAL ILLNESS
Not at all	80,470	9,104	71,366	30,713	40,653
A little or some	97,546	10,346	87,200	35,366	51,834
Quite a bit or a lot	15,677	2,465	13,211	6,614	6,597
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.9B – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Percentages, 2021
Perceived Negative Effect on Emotional or Mental Health	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG TOTAL POPULATION
Not at all	35.8	32.3	36.4	34.8	37.8
A little or some	49.7	46.2	50.2	47.9	52.3
Quite a bit or a lot	14.4	21.5	13.4	17.3	10.0
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR ANY MENTAL ILLNESS
Not at all	16.3	13.9	16.9	15.6	19.0
A little or some	47.5	44.3	48.3	45.9	52.1
Quite a bit or a lot	36.2	41.9	34.8	38.5	28.9
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR SERIOUS MENTAL ILLNESS
Not at all	11.4	9.9	12.0	12.0	12.0
A little or some	39.6	37.3	40.5	37.5	47.6
Quite a bit or a lot	48.9	52.7	47.5	50.5	40.4
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH NO PAST YEAR MENTAL ILLNESS
Not at all	41.5	41.5	41.5	42.3	41.0
A little or some	50.4	47.2	50.8	48.7	52.3
Quite a bit or a lot	8.1	11.2	7.7	9.1	6.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.10A – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021
Perceived Negative Effect on Emotional or Mental Health	Aged 12-17 (2021)	Aged 12-13 (2021)	Aged 14-15 (2021)	Aged 16-17 (2021)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG TOTAL POPULATION
Not at all	8,614	3,281	2,899	2,435
A little or some	11,970	4,170	3,802	3,998
Quite a bit or a lot	4,878	1,303	1,624	1,951
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE¹
Not at all	573	159	202	212
A little or some	2,160	478	657	1,025
Quite a bit or a lot	2,247	458	821	969
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE WITH SEVERE IMPAIRMENT^1,2
Not at all	391	89	150	152
A little or some	1,396	278	455	663
Quite a bit or a lot	1,856	399	693	764
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH NO PAST YEAR MDE¹
Not at all	7,850	3,047	2,620	2,182
A little or some	9,434	3,484	3,057	2,893
Quite a bit or a lot	2,445	764	731	950
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded. ¹ Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ² Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.10B – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021
Perceived Negative Effect on Emotional or Mental Health	Aged 12-17 (2021)	Aged 12-13 (2021)	Aged 14-15 (2021)	Aged 16-17 (2021)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG TOTAL POPULATION
Not at all	33.8	37.5	34.8	29.0
A little or some	47.0	47.6	45.7	47.7
Quite a bit or a lot	19.2	14.9	19.5	23.3
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE¹
Not at all	11.5	14.5	12.0	9.6
A little or some	43.4	43.7	39.1	46.5
Quite a bit or a lot	45.1	41.8	48.9	43.9
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH PAST YEAR MDE WITH SEVERE IMPAIRMENT^1,2
Not at all	10.7	11.6	11.5	9.7
A little or some	38.3	36.3	35.1	42.0
Quite a bit or a lot	50.9	52.1	53.4	48.4
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT ON EMOTIONAL OR MENTAL HEALTH AMONG PEOPLE WITH NO PAST YEAR MDE¹
Not at all	39.8	41.8	40.9	36.2
A little or some	47.8	47.8	47.7	48.0
Quite a bit or a lot	12.4	10.5	11.4	15.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded. ¹ Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ² Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.11A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 18 or Older; by Age Group and Past Year Mental Health Services Including Virtual Services Status, Numbers in Thousands, 2021
Perceived Effect on Access to Mental Health Services	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	52,076	6,912	45,164	24,041	21,123
Delays or cancellations in appointments	46,379	5,778	40,601	19,802	20,799
Delays in getting prescriptions	17,552	2,301	15,251	8,019	7,232
Unable to access needed care resulting in moderate or severe impact on health	11,968	1,869	10,099	5,831	4,268
PERCEIVED EFFECT AMONG PEOPLE WHO RECEIVED MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	26,503	4,448	22,055	13,755	8,301
Delays or cancellations in appointments	17,433	2,868	14,565	8,820	5,745
Delays in getting prescriptions	7,874	1,435	6,439	3,947	2,491
Unable to access needed care resulting in moderate or severe impact on health	4,834	947	3,887	2,551	1,336
PERCEIVED EFFECT AMONG PEOPLE WHO DID NOT RECEIVE MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	25,372	2,451	22,921	10,195	12,726
Delays or cancellations in appointments	28,805	2,884	25,921	10,904	15,017
Delays in getting prescriptions	9,620	865	8,755	4,060	4,695
Unable to access needed care resulting in moderate or severe impact on health	7,054	914	6,139	3,243	2,896
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. ¹ Mental health services including virtual services for adults includes inpatient treatment counseling; outpatient treatment counseling; use of prescription medication for problems with emotions, nerves, or mental health; and virtual services. Respondents with unknown mental health services including virtual services information were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.11B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 18 or Older; by Age Group and Past Year Mental Health Services Including Virtual Services Status, Percentages, 2021
Perceived Effect on Access to Mental Health Services	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	20.9	21.0	20.8	23.9	18.2
Delays or cancellations in appointments	18.6	17.6	18.7	19.6	17.9
Delays in getting prescriptions	7.0	7.0	7.0	8.0	6.2
Unable to access needed care resulting in moderate or severe impact on health	4.8	5.7	4.7	5.8	3.7
PERCEIVED EFFECT AMONG PEOPLE WHO RECEIVED MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	56.5	60.7	55.7	63.3	46.5
Delays or cancellations in appointments	37.1	39.1	36.8	40.6	32.1
Delays in getting prescriptions	16.8	19.6	16.3	18.1	14.0
Unable to access needed care resulting in moderate or severe impact on health	10.3	12.9	9.8	11.7	7.5
PERCEIVED EFFECT AMONG PEOPLE WHO DID NOT RECEIVE MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	12.6	9.7	13.0	13.0	13.0
Delays or cancellations in appointments	14.2	11.3	14.7	13.9	15.3
Delays in getting prescriptions	4.8	3.4	5.0	5.2	4.8
Unable to access needed care resulting in moderate or severe impact on health	3.5	3.6	3.5	4.1	3.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. ¹ Mental health services including virtual services for adults includes inpatient treatment counseling; outpatient treatment counseling; use of prescription medication for problems with emotions, nerves, or mental health; and virtual services. Respondents with unknown mental health services including virtual services information were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.12A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Numbers in Thousands, 2021
Perceived Effect on Access to Mental Health Services	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	52,076	6,912	45,164	24,041	21,123
Delays or cancellations in appointments	46,379	5,778	40,601	19,802	20,799
Delays in getting prescriptions	17,552	2,301	15,251	8,019	7,232
Unable to access needed care resulting in moderate or severe impact on health	11,968	1,869	10,099	5,831	4,268
PERCEIVED EFFECT AMONG ADULTS WITH PAST YEAR ANY MENTAL ILLNESS
Appointments moved from in-person to telehealth	21,888	3,963	17,926	11,660	6,265
Delays or cancellations in appointments	17,554	3,171	14,383	8,957	5,426
Delays in getting prescriptions	8,105	1,459	6,645	3,928	2,717
Unable to access needed care resulting in moderate or severe impact on health	6,156	1,280	4,875	3,201	1,674
PERCEIVED EFFECT AMONG ADULTS WITH PAST YEAR SERIOUS MENTAL ILLNESS
Appointments moved from in-person to telehealth	7,417	1,831	5,586	4,104	1,482
Delays or cancellations in appointments	5,685	1,464	4,221	3,014	1,208
Delays in getting prescriptions	3,151	735	2,415	1,622	794
Unable to access needed care resulting in moderate or severe impact on health	2,794	726	2,068	1,499	569
PERCEIVED EFFECT AMONG ADULTS WITH NO PAST YEAR MENTAL ILLNESS¹
Appointments moved from in-person to telehealth	30,187	2,950	27,238	12,380	14,858
Delays or cancellations in appointments	28,825	2,607	26,218	10,845	15,373
Delays in getting prescriptions	9,447	841	8,606	4,091	4,515
Unable to access needed care resulting in moderate or severe impact on health	5,812	588	5,223	2,629	2,594
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. ¹ Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.12B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Percentages, 2021
Perceived Effect on Access to Mental Health Services	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	20.9	21.0	20.8	23.9	18.2
Delays or cancellations in appointments	18.6	17.6	18.7	19.6	17.9
Delays in getting prescriptions	7.0	7.0	7.0	8.0	6.2
Unable to access needed care resulting in moderate or severe impact on health	4.8	5.7	4.7	5.8	3.7
PERCEIVED EFFECT AMONG ADULTS WITH PAST YEAR ANY MENTAL ILLNESS
Appointments moved from in-person to telehealth	38.8	35.9	39.5	41.5	36.2
Delays or cancellations in appointments	31.1	28.8	31.7	31.8	31.4
Delays in getting prescriptions	14.4	13.2	14.6	14.0	15.7
Unable to access needed care resulting in moderate or severe impact on health	10.9	11.6	10.7	11.4	9.7
PERCEIVED EFFECT AMONG ADULTS WITH PAST YEAR SERIOUS MENTAL ILLNESS
Appointments moved from in-person to telehealth	53.3	48.4	55.2	57.3	50.2
Delays or cancellations in appointments	40.9	38.7	41.7	42.1	40.9
Delays in getting prescriptions	22.7	19.4	23.9	22.6	26.9
Unable to access needed care resulting in moderate or severe impact on health	20.1	19.2	20.5	20.9	19.3
PERCEIVED EFFECT AMONG ADULTS WITH NO PAST YEAR MENTAL ILLNESS¹
Appointments moved from in-person to telehealth	15.6	13.5	15.9	17.1	15.0
Delays or cancellations in appointments	14.9	11.9	15.3	14.9	15.5
Delays in getting prescriptions	4.9	3.8	5.0	5.6	4.6
Unable to access needed care resulting in moderate or severe impact on health	3.0	2.7	3.0	3.6	2.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. ¹ Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.13A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 12 to 17; by Age Group and Past Year Mental Health Services Including Virtual Services Status, Numbers in Thousands, 2021
Perceived Effect on Access to Mental Health Services	Aged 12-17 (2021)	Aged 12-13 (2021)	Aged 14-15 (2021)	Aged 16-17 (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	3,605	981	1,176	1,448
Delays or cancellations in appointments	4,887	1,557	1,611	1,720
Delays in getting prescriptions	1,396	400	454	542
Unable to access needed care resulting in moderate to severe impact on health	926	233	333	359
PERCEIVED EFFECT AMONG PEOPLE WHO RECEIVED MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	2,507	622	860	1,024
Delays or cancellations in appointments	2,423	672	872	879
Delays in getting prescriptions	745	203	265	277
Unable to access needed care resulting in moderate to severe impact on health	534	94	231	209
PERCEIVED EFFECT AMONG PEOPLE WHO DID NOT RECEIVE MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	1,076	346	315	415
Delays or cancellations in appointments	2,389	823	733	834
Delays in getting prescriptions	630	183	186	262
Unable to access needed care resulting in moderate to severe impact on health	382	137	101	144
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. ¹ Mental health services including virtual services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services including virtual services information were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.13B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 12 to 17; by Age Group and Past Year Mental Health Services Including Virtual Services Status, Percentages, 2021
Perceived Effect on Access to Mental Health Services	Aged 12-17 (2021)	Aged 12-13 (2021)	Aged 14-15 (2021)	Aged 16-17 (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	14.5	11.8	14.4	17.3
Delays or cancellations in appointments	19.6	18.6	19.7	20.6
Delays in getting prescriptions	5.6	4.8	5.6	6.5
Unable to access needed care resulting in moderate to severe impact on health	3.7	2.8	4.1	4.3
PERCEIVED EFFECT AMONG PEOPLE WHO RECEIVED MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	38.9	30.8	40.8	44.4
Delays or cancellations in appointments	37.5	33.1	41.3	38.0
Delays in getting prescriptions	11.6	10.0	12.6	12.0
Unable to access needed care resulting in moderate to severe impact on health	8.3	4.7	10.9	9.1
PERCEIVED EFFECT AMONG PEOPLE WHO DID NOT RECEIVE MENTAL HEALTH SERVICES INCLUDING VIRTUAL SERVICES IN PAST YEAR¹
Appointments moved from in-person to telehealth	5.9	5.7	5.3	6.9
Delays or cancellations in appointments	13.2	13.4	12.3	13.9
Delays in getting prescriptions	3.5	3.0	3.1	4.4
Unable to access needed care resulting in moderate to severe impact on health	2.1	2.2	1.7	2.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. ¹ Mental health services including virtual services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services including virtual services information were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.14A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021
Perceived Effect on Access to Mental Health Services	Aged 12-17 (2021)	Aged 12-13 (2021)	Aged 14-15 (2021)	Aged 16-17 (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	3,605	981	1,176	1,448
Delays or cancellations in appointments	4,887	1,557	1,611	1,720
Delays in getting prescriptions	1,396	400	454	542
Unable to access needed care resulting in moderate to severe impact on health	926	233	333	359
PERCEIVED EFFECT AMONG PEOPLE WHO HAD MDE IN PAST YEAR¹
Appointments moved from in-person to telehealth	1,285	190	446	649
Delays or cancellations in appointments	1,502	282	525	695
Delays in getting prescriptions	438	103	158	178
Unable to access needed care resulting in moderate to severe impact on health	373	56	154	163
PERCEIVED EFFECT AMONG PEOPLE WHO HAD MDE WITH SEVERE IMPAIRMENT IN PAST YEAR^1,2
Appointments moved from in-person to telehealth	992	160	353	478
Delays or cancellations in appointments	1,146	208	432	506
Delays in getting prescriptions	362	92	126	144
Unable to access needed care resulting in moderate to severe impact on health	313	51	132	130
PERCEIVED EFFECT AMONG PEOPLE WHO HAD NO MDE IN PAST YEAR¹
Appointments moved from in-person to telehealth	2,171	724	690	758
Delays or cancellations in appointments	3,214	1,180	1,044	990
Delays in getting prescriptions	916	277	287	351
Unable to access needed care resulting in moderate to severe impact on health	528	172	165	191
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. ¹ Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ² Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.14B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Services: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021
Perceived Effect on Access to Mental Health Services	Aged 12-17 (2021)	Aged 12-13 (2021)	Aged 14-15 (2021)	Aged 16-17 (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	14.5	11.8	14.4	17.3
Delays or cancellations in appointments	19.6	18.6	19.7	20.6
Delays in getting prescriptions	5.6	4.8	5.6	6.5
Unable to access needed care resulting in moderate to severe impact on health	3.7	2.8	4.1	4.3
PERCEIVED EFFECT AMONG PEOPLE WHO HAD MDE IN PAST YEAR¹
Appointments moved from in-person to telehealth	26.4	18.8	27.0	29.4
Delays or cancellations in appointments	30.8	28.0	31.7	31.4
Delays in getting prescriptions	9.0	10.0	9.5	8.0
Unable to access needed care resulting in moderate to severe impact on health	7.7	5.5	9.3	7.4
PERCEIVED EFFECT AMONG PEOPLE WHO HAD MDE WITH SEVERE IMPAIRMENT IN PAST YEAR^1,2
Appointments moved from in-person to telehealth	27.7	22.1	27.6	30.3
Delays or cancellations in appointments	32.0	29.0	33.7	32.0
Delays in getting prescriptions	10.1	12.6	9.9	9.1
Unable to access needed care resulting in moderate to severe impact on health	8.8	7.1	10.3	8.3
PERCEIVED EFFECT AMONG PEOPLE WHO HAD NO MDE IN PAST YEAR¹
Appointments moved from in-person to telehealth	11.3	10.4	10.9	12.6
Delays or cancellations in appointments	16.6	16.9	16.5	16.5
Delays in getting prescriptions	4.8	4.0	4.6	5.9
Unable to access needed care resulting in moderate to severe impact on health	2.7	2.5	2.6	3.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to mental health services did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health services were excluded. ¹ Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. ² Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.15A – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC			Loss of Permanent Housing Because of Pandemic (2021)
Demographic Characteristic	All of the Time or Nearly All of the Time (2021)	Some of the Time or Rarely (2021)	Never (2021)	Loss of Permanent Housing Because of Pandemic (2021)
TOTAL	41,569	122,750	110,314	4,176
AGE GROUP
12-20	4,008	15,045	18,779	552
21 or Older	37,561	107,705	91,535	3,624
12-17	1,962	9,005	14,038	254
18 or Older	39,606	113,744	96,276	3,922
18-25	6,374	15,955	10,475	751
26 or Older	33,232	97,790	85,800	3,171
GENDER
Male	18,630	56,022	59,615	2,387
Female	22,939	66,728	50,699	1,789
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	32,153	99,962	94,164	3,333
White	20,050	73,367	75,292	1,897
Black or African American	8,232	14,569	10,618	1,018
AIAN	454	883	441	65
NHOPI	327	*	254	46
Asian	2,016	8,331	5,808	118
Two or More Races	1,074	2,433	1,751	189
Hispanic or Latino	9,416	22,788	16,150	843
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.15B – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2021
Demographic Characteristic	HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC			Loss of Permanent Housing Because of Pandemic (2021)
Demographic Characteristic	All of the Time or Nearly All of the Time (2021)	Some of the Time or Rarely (2021)	Never (2021)	Loss of Permanent Housing Because of Pandemic (2021)
TOTAL	15.1	44.7	40.2	1.5
AGE GROUP
12-20	10.6	39.8	49.6	1.4
21 or Older	15.9	45.5	38.7	1.5
12-17	7.8	36.0	56.1	1.0
18 or Older	15.9	45.6	38.6	1.6
18-25	19.4	48.6	31.9	2.3
26 or Older	15.3	45.1	39.6	1.5
GENDER
Male	13.9	41.7	44.4	1.8
Female	16.3	47.5	36.1	1.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.2	44.2	41.6	1.5
White	11.9	43.5	44.6	1.1
Black or African American	24.6	43.6	31.8	3.0
AIAN	25.6	49.6	24.8	3.6
NHOPI	34.0	*	26.4	4.8
Asian	12.5	51.6	36.0	0.7
Two or More Races	20.4	46.3	33.3	3.6
Hispanic or Latino	19.5	47.1	33.4	1.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.16A – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC			Loss of Permanent Housing Because of Pandemic (2021)
Geographic/Socioeconomic Characteristic	All of the Time or Nearly All of the Time (2021)	Some of the Time or Rarely (2021)	Never (2021)	Loss of Permanent Housing Because of Pandemic (2021)
TOTAL	41,569	122,750	110,314	4,176
GEOGRAPHIC REGION
Northeast	6,829	21,388	19,839	441
Midwest	7,224	25,305	24,641	860
South	17,164	46,351	40,885	1,792
West	10,352	29,706	24,949	1,083
COUNTY TYPE
Large Metro	22,261	68,238	58,964	2,091
Small Metro	12,846	37,428	34,134	1,244
Nonmetro	6,461	17,084	17,216	840
Urbanized	2,155	6,655	6,654	265
Less Urbanized	3,575	8,612	8,797	470
Completely Rural	732	1,817	1,765	105
POVERTY LEVEL¹
Less Than 100%	13,356	17,057	11,247	1,877
100-199%	11,905	27,036	15,615	1,166
200% or More	16,295	78,621	83,403	1,133
HEALTH INSURANCE²
Private	15,891	76,062	74,426	1,046
Medicaid/CHIP	15,586	24,293	15,431	1,924
Other³	9,206	29,645	36,563	685
No Coverage	7,063	11,878	7,117	1,029
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.16B – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC			Loss of Permanent Housing Because of Pandemic (2021)
Geographic/Socioeconomic Characteristic	All of the Time or Nearly All of the Time (2021)	Some of the Time or Rarely (2021)	Never (2021)	Loss of Permanent Housing Because of Pandemic (2021)
TOTAL	15.1	44.7	40.2	1.5
GEOGRAPHIC REGION
Northeast	14.2	44.5	41.3	0.9
Midwest	12.6	44.3	43.1	1.5
South	16.4	44.4	39.2	1.7
West	15.9	45.7	38.4	1.7
COUNTY TYPE
Large Metro	14.9	45.7	39.5	1.4
Small Metro	15.2	44.3	40.4	1.5
Nonmetro	15.9	41.9	42.2	2.0
Urbanized	13.9	43.0	43.0	1.7
Less Urbanized	17.0	41.0	41.9	2.2
Completely Rural	17.0	42.1	40.9	2.4
POVERTY LEVEL¹
Less Than 100%	32.1	40.9	27.0	4.5
100-199%	21.8	49.6	28.6	2.1
200% or More	9.1	44.1	46.8	0.6
HEALTH INSURANCE²
Private	9.6	45.7	44.7	0.6
Medicaid/CHIP	28.2	43.9	27.9	3.4
Other³	12.2	39.3	48.5	0.9
No Coverage	27.1	45.6	27.3	3.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.17A – Perceived COVID-19 Pandemic Effect on Access to Medical Care: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2021
Perceived Effect on Access to Medical Care	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	82,378	3,590	78,788	7,153	71,635	31,924	39,711
Delays or cancellations in appointments or preventative services	67,346	4,318	63,027	5,910	57,117	24,990	32,127
Delays in getting prescriptions	23,243	1,527	21,716	2,378	19,338	9,277	10,062
Unable to access needed care resulting in moderate or severe impact on health	14,189	709	13,481	1,449	12,032	5,849	6,183
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to medical care did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to medical care were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220708

Table 10.17B – Perceived COVID-19 Pandemic Effect on Access to Medical Care: Among People Aged 12 or Older; by Age Group, Percentages, 2021
Perceived Effect on Access to Medical Care	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)	Aged 26-49 (2021)	Aged 50+ (2021)
PERCEIVED EFFECT AMONG TOTAL POPULATION
Appointments moved from in-person to telehealth	30.0	14.5	31.6	21.8	33.0	31.7	34.2
Delays or cancellations in appointments or preventative services	24.5	17.4	25.2	18.0	26.3	24.8	27.7
Delays in getting prescriptions	8.5	6.2	8.7	7.3	8.9	9.2	8.7
Unable to access needed care resulting in moderate or severe impact on health	5.2	2.9	5.4	4.4	5.5	5.8	5.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Respondents could report that the questions about access to medical care did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect. NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to medical care were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.